Myriad Genetics (MYGN) Research & Development (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Research & Development of $27.1 million for Q1 2026, down 1.45% year-over-year from $27.5 million in Q1 2025, and up 6.27% quarter-over-quarter from $25.5 million in Q4 2025.
Myriad Genetics (MYGN) Research & Development (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has reported Research & Development for 18 consecutive years, with $27.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 1.45% year-over-year to $27.1 million; the TTM figure through Mar 2026 stood at $152.7 million (up 407.31% YoY), while the FY2025 annual figure was $106.8 million, down 5.82% from the prior year.
- Research & Development improved to $27.1 million in Q1 2026 per MYGN's latest filing, from $25.5 million in the prior quarter.
- Across five years, Research & Development topped out at $204.8 million in Q4 2022 and bottomed at -$98.7 million in Q4 2024.
- Historically, Research & Development has averaged $35.7 million across 5 years, with a median of $25.5 million in 2025.
- Annual changes were most pronounced in 2022 — Research & Development jumped 899.02% — and 2024, when it slumped 570.0%.
- Myriad Genetics' Research & Development stood at $204.8 million in 2022, then plunged by 89.75% to $21.0 million in 2023, then plunged by 570.0% to -$98.7 million in 2024, then jumped by 125.84% to $25.5 million in 2025, then gained by 6.27% to $27.1 million in 2026.
- Business Quant data shows MYGN's Research & Development at $27.1 million in Q1 2026, $25.5 million in Q4 2025, and $28.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 171.28 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | - |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 210.70 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | - |
| 10 | Myriad Genetics | 294.22 Mn | 169.82 Mn | 137.60 Mn | 27.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.10 Mn |
| Dec 31, 2025 | 25.50 Mn |
| Sep 30, 2025 | 28.20 Mn |
| Jun 30, 2025 | 71.90 Mn |
| Mar 31, 2025 | 27.50 Mn |
| Dec 31, 2024 | -98.70 Mn |
| Sep 30, 2024 | 28.50 Mn |
| Jun 30, 2024 | 72.80 Mn |
| Mar 31, 2024 | 69.40 Mn |
| Dec 31, 2023 | 21.00 Mn |
| Sep 30, 2023 | 24.00 Mn |
| Jun 30, 2023 | 21.20 Mn |
| Mar 31, 2023 | 22.50 Mn |
| Dec 31, 2022 | 204.80 Mn |
| Sep 30, 2022 | 20.50 Mn |
| Jun 30, 2022 | 20.30 Mn |
| Mar 31, 2022 | 21.20 Mn |
| Dec 31, 2021 | 20.50 Mn |
| Sep 30, 2021 | 18.80 Mn |
| Jun 30, 2021 | 19.50 Mn |